Alembic Pharmaceuticals Limited

APLLTD

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Jun 20261,868

    Quarter₹ croreYoY
    Mar 20241,475+12.8%
    Jun 20241,476+10.8%
    Sept 20241,580+6.9%
    Dec 20241,406-11.5%
    Jun 20251,494+1.3%
    Sept 20251,796+13.7%
    Dec 20251,642+16.8%
    Mar 20261,719—
    Jun 20261,868+25.0%
  • ₹ crore

    Jun 202614

    Quarter₹ crore
    Mar 20247
    Jun 20243
    Sept 202416
    Dec 202415
    Jun 20258
    Sept 202511
    Dec 202511
    Mar 202626
    Jun 202614
  • ₹ crore

    Jun 20261,882

    Quarter₹ crore
    Mar 20241,482
    Jun 20241,479
    Sept 20241,596
    Dec 20241,422
    Jun 20251,502
    Sept 20251,808
    Dec 20251,653
    Mar 20261,745
    Jun 20261,882
  • Cost structure
  • ₹ crore

    Jun 2026416

    Quarter₹ crore
    Mar 2024355
    Jun 2024357
    Sept 2024368
    Dec 2024369
    Jun 2025396
    Sept 2025408
    Dec 2025401
    Mar 2026407
    Jun 2026416
  • ₹ crore

    Jun 20261,626

    Quarter₹ crore
    Mar 20241,266
    Jun 20241,266
    Sept 20241,409
    Dec 20241,318
    Jun 20251,376
    Sept 20251,591
    Dec 20251,472
    Mar 20261,546
    Jun 20261,626
  • Exceptional items and tax
  • ₹ crore

    Jun 2026256

    Quarter₹ crore
    Mar 2024216
    Jun 2024213
    Sept 2024200
    Dec 2024104
    Jun 2025126
    Sept 2025216
    Dec 2025139
    Mar 2026173
    Jun 2026256
  • ₹ crore

    Jun 202659

    Quarter₹ crore
    Mar 202414
    Jun 202437
    Sept 202434
    Dec 202418
    Jun 202522
    Sept 202537
    Dec 202524
    Mar 2026-70
    Jun 202659
  • Profit
  • ₹ crore

    Jun 2026197

    Quarter₹ croreYoY
    Mar 2024202+54.6%
    Jun 2024176+80.7%
    Sept 2024166+23.9%
    Dec 202486-63.2%
    Jun 2025104-41.2%
    Sept 2025179+8.2%
    Dec 2025114+33.4%
    Mar 2026243—
    Jun 2026197+90.3%
  • Per share
  • ₹ per share

    Jun 202610.02

    Quarter₹ per share
    Mar 202410.27
    Jun 20248.96
    Sept 20248.43
    Dec 20244.37
    Jun 20255.27
    Sept 20259.12
    Dec 20255.82
    Mar 202612.37
    Jun 202610.02
  • Leverage
  • Debt to equity

    times

    Jun 20260.00x

    Quartertimes
    Mar 20240.00x
    Jun 20240.00x
    Sept 20240.00x
    Dec 20240.00x
    Jun 20250.00x
    Sept 20250.00x
    Dec 20250.00x
    Mar 20260.00x
    Jun 20260.00x
₹ croreMar 2024Jun 2024Sept 2024Dec 2024Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Income
1,4751,4761,5801,4061,4941,7961,6421,7191,868
Revenue YoY+12.8%+10.8%+6.9%-11.5%+1.3%+13.7%+16.8%—+25.0%
731615811112614
1,4821,4791,5961,4221,5021,8081,6531,7451,882
Cost structure
355357368369396408401407416
1,2661,2661,4091,3181,3761,5911,4721,5461,626
Exceptional items and tax
216213200104126216139173256
14373418223724-7059
Profit
20217616686104179114243197
Net profit YoY+54.6%+80.7%+23.9%-63.2%-41.2%+8.2%+33.4%—+90.3%
Per share
10.278.968.434.375.279.125.8212.3710.02
Leverage
Debt to equity0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x

Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.